Human herpesviruses 6, 7 and 8

Reviews and Research in Medical Microbiology

Volumn 11, Issue 1, 2000, Pages 1-13

  Dollard, Sheila C ^a   Pellett, Philip E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

HHV 7; HHV 8; Human herpesvirus (HHV) 6; Kaposi's sarcoma; Post transplant disease; Roseola

Indexed keywords

ACICLOVIR; CIDOFOVIR; FOSCARNET; GANCICLOVIR; PROTEINASE INHIBITOR;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; EXANTHEMA SUBITUM; FEVER; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN HERPESVIRUS 8; IMMUNE DEFICIENCY; KAPOSI SARCOMA; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NONHODGKIN LYMPHOMA; ORGAN TRANSPLANTATION; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SINUSITIS; VIRUS INFECTION;

EID: 0034058007     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013542-200011010-00001     Document Type: Review

References (70)

1. Salahuddin SZ, Ablashi DV, Markham PD, et al.: Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986, 234:596-601.
2. Braun DK, Dominguez G, Pellett PE: Human herpesvirus 6. Clin Microbiol Rev 1997, 10:521-567.
3. Rotola A, Ravaioli T, Gonelli A, Dewhurst S, Cassai E, Di Luca D: U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in culture. Proc Natl Acad Sci USA 1998, 95:13911-13916.
4. Katsafanas GC, Schirmer EC, Wyatt LS, Frenkel N: In vitro activation of human herpesvirus 6 and 7 from latency. Proc Natl Acad Sci USA 1996, 93:9788-9792.
5. Di Luca D, Mirandola P, Ravaioli T, Bigoni B, Cassai E: Distribution of HHV-6 variants in human tissues. Infect Agents Dis 1996, 5:203-214.
6. Cone RW, Huang ML, Hackman RC, Corey L: Coinfection with human herpesvirus 6 variants A and B in lung tissue. J Clin Microbiol 1996, 34:877-881.
7. Hall CB, Caserta MT, Schnabel KC, et al.: Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A. Clin Infect Dis 1998, 26:132-137.
8. Adams O, Krempe C, Kogler G, Wernet P, Scheid A: Congenital infections with human herpesvirus 6. J Infect Dis 1998, 178:544-546.
9. Daibata M, Taguchi T, Sawada T, Taguchi H, Miyoshi I: Chromosomal transmission of human herpesvirus 6 DNA in acute lymphoblastic leukaemia. Lancet 1998, 352:543-544.
10. Kasolo FC, Mpabalwani E, Gompels UA: Infection with AIDS-related herpesviruses in human immunodeficiency virus-negative infants and endemic childhood Kaposi's sarcoma in Africa. J Gen Virol 1997, 78:847-855.
11. Black JB, Durigon E, Kite-Powell K, et al.: Seroconversion to human herpesvirus 6 and human herpesvirus 7 among Brazilian children with clinical diagnoses of measles or rubella. Clin Infect Dis 1996, 23:1156-1158.
12. Yamanishi K, Okuno T, Shiraki K, et al.: Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988, i:1065-1067.
13. Asano Y, Yoshikawa T, Suga S, et al.: Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum). Pediatrics 1994, 93:104-108.
14. Asano Y, Yoshikawa T, Kajita Y, et al.: Fatal encephalitis/encephalopathy in primary human herpesvirus-6 infection. Arch Dis Child 1992, 67:1484-1485.
15. Hall CB, Long CE, Schnabel KC, et al.: Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med 1994, 331:432-438.
16. Kondo K, Nagafuji H, Hata A, Tomomori C, Yamanishi K: Association of human herpesvirus 6 infection of the central nervous system with recurrence of febrile convulsions. J Infect Dis 1993, 167:1197-1200.
17. Prezioso PJ, Cangiarella J, Lee M, et al.: Fatal disseminated infection with human herpesvirus-6. J Pediatr 1992, 120:921-923.
18. Kitamura K, Ohta H, Ihara T, et al.: Idiopathic thrombocytopenic purpura after human herpesvirus 6 infection. Lancet 1994, 344:830.
19. Yoshikawa T, Suga S, Asano Y, et al.: Human herpesvirus-6 infection in bone marrow transplantation. Blood 1991, 78:1381-1384.
20. Drobyski WR, Knox KK, Majewski D, Carrigan DR: Fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med 1994, 330:1356-1360.
21. Lusso P, Malnati MS, Garzino-Demo A, Crowley RW, Long EO, Gallo RC: Infection of natural killer cells by human herpesvirus 6. Nature 1993, 362:458-462.
22. Razzaque A: Oncogenic potential of human herpesvirus-6 DNA. Oncogene 1990, 5:1365-1370.
23. Challoner PB, Smith KT, Parker JD, et al.: Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA 1995, 92: 7740-7444.
24. Black JB, Schwarz TF, Patton JL, et al.: Evaluation of immunoassays for detection of antibodies to human herpesvirus 7. Clin Diagn Lab Immunol 1996, 3:79-83.
25. Parker CA, Weber JM: An enzyme-linked immunosorbent assay for the detection of IgG and IgM antibodies to human herpesvirus type 6. J Virol Method 1993, 41:265-276.
26. Suga S, Yoshikawa T, Asano Y, et al.: IgM neutralizing antibody responses to human herpesvirus-6 in patients with exanthem subitum or organ transplantation. Microbiol Immunol 1992, 36:495-506.
27. Patnaik M, Komaroff AL, Conley E, Ojo-Amaize EA, Peter JB: Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p41/38) in patients with chronic fatigue syndrome. J Infect Dis 1995, 172:1264-1267.
28. Chiu SS, Cheung Cy, Tse CY, Peiris M: Early diagnosis of primary human herpesvirus 6 infection in childhood: serology, polymerase chain reaction, and virus load. J Infect Dis 1998, 178:1250-1256.
29. 4 T cells. Proc Natl Acad Sci USA 1990, 87:748-752.
30. Black JB, Pellett PE: Human herpesvirus 7. Rev Med Virol 1999, 9:245-262.
31. Nicholas J: Determination and analysis of the complete nucleotide sequence of human herpesvirus 7. J Virol 1996, 70:5975-5989.
32. Lusso P, Secchiero P, Crowley RW, Garzino-Demo A, Berneman ZN, Gallo RC: CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus. Proc Natl Acad Sci USA 1994, 91:3872-3876.
33. Black JB, Burns DA, Goldsmith CS, et al.: Biologic properties of human herpesvirus 7 strain SB. Virus Res 1997, 52:25-41.
34. Wyatt LS, Frenkel N: Human herpesvirus 7 is a constitutive inhabitant of adult human saliva. J Virol 1992, 66:3206-3209.
35. Di Luca D, Mirandola P, Ravaioli T, et al.: Human herpesviruses 6 and 7 in salivary glands and shedding in saliva of healthy and human immunodeficiency virus positive individuals. J Med Virol 1995, 45:462-468.
36. Kempf W, Adams V, Mirandola P, et al.: Persistence of human herpesvirus 7 in normal tissues detected by expression of a structural antigen. J Infect Dis 1998, 178:841-845.
37. Kidd IM, Clark DA, Ait-Khaled M, Griffiths PD, Emery VC: Measurement of human herpesvirus 7 load in peripheral blood and saliva of healthy subjects by quantitative polymerase chain reaction. J Infect Dis 1996, 174:396-401.
38. Okuno T, Oishi H, Hayashi K, Nonogaki M, Tanaka K, Yamanishi K: Human herpesvirus 6 and 7 in cervixes of pregnant women. J Clin Microbiol 1995, 33:1968-1970.
39. Fujisaki H, Tanaka-Taya K, Tanabe H, et al.: Detection of human herpesvirus 7 (HHV-7) DNA in breast milk by polymerase chain reaction and prevalence of HHV-7 antibody in breast-fed and bottle-fed children. J Med Virol 1998, 56:275-279.
40. Tanaka K, Kondo T, Torigoe S, Okada S, Mukai T, Yamanishi K: Human herpesvirus 7: another causal agent for roseola (exanthem subitum). J Pediatr 1994, 125:1-5.
41. Caserta MT, Hall CB, Schnabel K, Long CE, D'Heron N: Primary human herpesvirus 7 infection: a comparison of human herpesvirus 7 and human herpesvirus 6 infections in children. J Pediatr 1998, 133:386-389.
42. Drago F, Ranieri E, Malaguti F, Losi E, Rebora A: Human herpesvirus 7 in pityriasis rosea. Lancet 1997, 349:1367-1368.
43. Kempf W, Adams WV, Kleinhans M, et al.: Pityriasis rosea is not associated with human herpesvirus 7. Arch Derm 1999, 135:1070-1072.
44. Nakagawa N, Mukai T, Sakamoto J, et al.: Antigenic analysis of human herpesvirus 7 (HHV-7) and HHV-6 using immune sera and monoclonal antibodies against HHV-7. J Gen Virol 1997, 78:1131-1137.
45. Tsukazaki T, Yoshida M, Namba H, Yamada M, Shimizu N, Nii S: Development of a dot blot neutralizing assay for HHV-6 and HHV-7 using specific monoclonal antibodies. J Virol Method 1998, 73:141-149.
46. Kidd IM, Clark DA, Bremner JA, Pillay D, Griffiths PD, Emery VC: A multiplex PCR assay for the simultaneous detection of human herpesvirus 6 and human herpesvirus 7, with typing of HHV-6 by enzyme cleavage of PCR products. J Virol Method 1998, 70:29-36.
47. Chang Y, Cesarman E, Pessin MS, et al.: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865-1869.
48. Flore O, Rafii S, Ely S, O'Leary JJ, Hyjek EM, Cesarman E: Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 1998, 394:588-592.
49. Renne R, Zhong W, Herndier B, et al.: Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nature Med 1996, 2:342-346.
50. Mesri EA, Cesarman E, Arvanitakis L, et al.: Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J Exp Med 1996, 183:2385-2390.
51. Renne R, Blackbourn D, Whitby D, Levy J, Ganem D: Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells. J Virol 1998, 72:5182-5188.
52. Zhong W, Ganem D: Characterization of ribonucleoprotein complexes containing an abundant polyadenylated nuclear RNA encoded by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). J Virol 1997, 71:1207-1212.
53. Staskus KA, Zhong W, Gebhard K, et al.: Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 1997, 71: 715-719.
54. Sturzl M, Blasig C, Schreier A, et al.: Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma. Int J Cancer 1997, 72:68-71.
55. Mayama S, Cuevas JE, Sheldon J, et al.: Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer 1998, 77:817-820.
56. Bourboulia D, Whitby D, Boshoff C, et al.: Serologic evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus. JAMA 1998, 280:31-32.
57. Kennedy MM, Cooper K, Howells DD, et al.: Identification of HHV8 in early Kaposi's sarcoma: implications for Kaposi's sarcoma pathogenesis. Molec Pathol 1998, 51: 14-20.
58. Gao SJ, Kingsley L, Hoover DR, et al.: Scroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996, 335: 233-241.
59. Angeloni A, Heston L, Uccini S, et al.: High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia. J Infect Dis 1998, 177:1715-1718.
60. Brodt HR, Kamps BS, Helm EB, Schofer H, Mitrou P: Kaposi's sarcoma in HIV infection: impact on opportunistic infections and survival. AIDS 1998, 12: 1475-1481.
61. Parravicini C, Olsen SJ, Capra M, et al.: Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. Blood 1997, 90:2826-2829.
62. Olsen SJ, Tarte K, Sherman W, et al.: Evidence against KSHV infection in the pathogenesis of multiple myeloma. Virus Res 1998, 57:197-202.
63. Gao S-J, Kingsley L, Li M, et al.: KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nature Med 1996, 2:925-928.
64. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D: The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution in KS risk groups and evidence for sexual transmission. Nature Med 1996, 2:918-924.
65. Lennette ET, Blackbourn DJ, Levy JA: Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996, 348: 858-861.
66. Simpson GR, Schulz TF, Whitby D, et al.: Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996, 348:1133-1138.
67. Rainbow L, Platt GM, Simpson GR, et al.: The 222-to 234-kilodalton latent nuclear protein (LAN) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol 1997, 71: 5915-5921.
68. Lin SF, Sun R, Heston L, et al.: Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen. J Virol 1997, 71:3069-3076.
69. Pau CP, Lam LL, Spira TJ, et al.: Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein. J Clin Microbiol 1998, 36:1574-1577.
70. Martin DF, Kuppermann BD, Wolitz RA, et al.: Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. N Engl J Med 1999, 340:1063-1070.